Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part A: Chemical analysis and drug use estimates

Science of the Total Environment

Volumn 487, Issue 1, 2014, Pages 629-641

  Baker, David R ^a   Barron, Leon ^b   Kasprzyk Hordern, Barbara ^c  

^a Waters Mass Spectrometry Center   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c University of Bath Claverton Down   (United Kingdom)

Author keywords

Consumption; Illicit drugs; Pharmaceuticals; Sewage epidemiology; Wastewater analysis

Indexed keywords

DRUG PRODUCTS; METABOLITES; SEWAGE; WASTEWATER DISPOSAL;

CONSUMPTION; CONSUMPTION PATTERNS; DIRECT DISPOSAL; ILLICIT DRUG; PARENT COMPOUNDS; PHARMACEUTICAL DRUGS; SEWAGE EPIDEMIOLOGIES; WASTEWATER ANALYSIS;

CHEMICAL ANALYSIS;

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; CENTRAL STIMULANT AGENT; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DIAZEPAM; DIHYDROCODEINE; DOSULEPIN; DRUG; DRUG METABOLITE; ILLICIT DRUG; METHADONE; MORPHINE DERIVATIVE; OPIATE; OXYCODONE; PSYCHEDELIC AGENT; RECREATIONAL DRUG; TEMAZEPAM; TRAMADOL; VENLAFAXINE;

BIOMARKER; CHEMICAL ANALYSIS; DRUG; EPIDEMIOLOGY; METABOLITE; WASTEWATER;

ARTICLE; CHEMICAL ANALYSIS; DRUG ABUSE; DRUG MARKETING; DRUG MONITORING; DRUG TRAFFIC; DRUG USE; NATIONAL HEALTH SERVICE; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM; WASTE WATER; WATER ANALYSIS;

ENGLAND; UNITED KINGDOM;

CONSUMPTION; ILLICIT DRUGS; PHARMACEUTICALS; SEWAGE EPIDEMIOLOGY; WASTEWATER ANALYSIS;

ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84900532312     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.11.107     Document Type: Article

References (56)

1. Adamowicz P., Kala M. Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 2005, 29(5):376-382.
2. Baker D.R., Kasprzyk-Hordern B. Critical evaluation of methodology commonly used in sample collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by solid phase extraction and liquid chromatography-mass spectrometry. J Chromatogr A 2011, 1218(44):8036-8059.
3. Baker D.R., Kasprzyk-Hordern B. Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J Chromatogr A 2011, 1218(12):1620-1631.
4. Baker D.R., Kasprzyk-Hordern B. Multi-residue determination of the sorption of illicit drugs and pharmaceuticals to wastewater suspended particulate matter using pressurised liquid extraction, solid phase extraction and liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A 2011, 1218(44):7901-7913.
5. Baker D.R., Kasprzyk-Hordern B. Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment: new developments. Sci Total Environ 2013, 454-455:442-456.
6. Banta-Green C.J., Field J.A., Chiaia A.C., Sudakin D.L., Power L., de Montigny L. The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater. Addiction 2009, 104(11):1874-1880.
7. Barron L., Havel J., Purcell M., Szpak M., Kelleher B., Paull B. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks. Analyst 2009, 134(4):663-670.
8. Baselt R.C. Disposition of toxic drugs and chemicals in man 2008, Biomedical Publications, California, USA. 7th ed.
9. Boleda M.R., Galceran M.T., Ventura F. Monitoring of opiates, cannabinoids and their metabolites in wastewater, surface water and finished water in Catalonia, Spain. Water Res 2009, 43(4):1126-1136.
10. Bones J., Thomas K.V., Paull B. Using environmental analytical data to estimate levels of community consumption of illicit drugs and abused pharmaceuticals. J Environ Monit 2007, 9(7):701-707.
11. Castiglioni S., Bijlsma L., Covaci A., Emke E., Hernandez F., Reid M., et al. Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. Environ Sci Technol 2013, 47(3):1452-1460.
12. Daughton C.G. Illicit Drugs in Municipal Sewage: Proposed New Nonintrusive Tool to Heighten Public Awareness of Societal Use of Illicit/Abused Drugs and Their Potential for Ecological Consequences. ACS Symposium Series 2001, 791:348-364. American Chemical Society, Washington, D.C. C. Daughton, T. Jones-Lepp (Eds.).
13. Elliott H.W., Parker K.D., Wright J.A., Nomof N. Actions and metabolism of heroin administered by continuous intravenous infusion to man. Clin Pharmacol Ther 1971, 12(5).
14. EMCDDA The state of the drugs problem in Europe. Annual Report 2009. Lisbon, Portugal, European Monitoring Centre for Drugs and Drug Addiction 2009.
15. EMCDDA Drug profiles > heroin Retrieved 01/08/11, from. http://www.emcdda.europa.eu/publications/drug-profiles/heroin.
16. Garnier J., Laroche L., Pinault S. Determining the domestic specific loads of two wastewater plants of the Paris conurbation (France) with contrasted treatments: a step for exploring the effects of the application of the European Directive. Water Res 2006, 40(17):3257-3266.
17. González-Mariño I., Quintana J.B., Rodríguez I., Sánchez-Méndez N., Cela R. Transformation of cocaine during water chlorination. Anal Bioanal Chem 2012, 404(10):3135-3144.
18. Harman C., Reid M., Thomas K.V. In situ calibration of a passive sampling device for selected illicit drugs and their metabolites in wastewater, and subsequent year-long assessment of community drug usage. Environ Sci Technol 2011, 45(13):5676-5682.
19. Home Office Drug misuse declared: findings from the 2010/11 British crime survey 2011, Home Office, London. K. Smith, J. Flatley (Eds.).
20. Huerta-Fontela M., Galceran M.T., Martin-Alonso J., Ventura F. Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci Total Environ 2008, 397(1-3):31-40.
21. Hörsing M., Ledin A., Grabic R., Fick J., Tysklind M., la Cour Jansen J., et al. Determination of sorption of seventy-five pharmaceuticals in sewage sludge. Water Res 2011, 45(15):4470-4482.
22. INCB Narcotic drugs: estimated world requirements for 2009 2008, International Narcotics Control Board, Vienna.
23. Irvine R.J., Kostakis C., Felgate P.D., Jaehne E.J., Chen C., White J.M. Population drug use in Australia: a wastewater analysis. Forensic Sci Int 2011, 210(1-3):69-73.
24. Jones H.E., Hickman M., Kasprzyk-Hordern B., Welton N.J., Baker D., Ades A.E. Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: Placing back-calculations in a formal statistical framework. Sci Total Environ 2013, (under review).
25. Karolak S., Nefau T., Bailly E., Solgadi A., Levi Y. Estimation of illicit drugs consumption by wastewater analysis in Paris area (France). Forensic Sci Int 2010, 200(1-3):153-160.
26. Kasprzyk-Hordern B., Baker D.R. Estimation of community-wide drugs use via stereoselective profiling of sewage. Sci Total Environ 2012, 423:142-150.
27. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Illicit drugs and pharmaceuticals in the environment-forensic applications of environmental data. Part 1: estimation of the usage of drugs in local communities. Environ Pollut 2009, 157(6):1773-1777.
28. Kasprzyk-Hordern B., Kondakal V.V.R., Baker D.R. Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A 2010, 1217(27):4575-4586.
29. Khan U., Nicell J.A. Refined sewer epidemiology mass balances and their application to heroin, cocaine and ecstasy. Environ Int 2011, 37(7):1236-1252.
30. Kim E.-m, Lee J.-s., Choi S.-k., Lim M.-a., Chung H.-s. Analysis of ketamine and norketamine in urine by automatic solid-phase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry (PCI-GC-MS). Forensic Sci Int 2008, 174(2-3):197-202.
31. Kinyua J., Anderson T.A. Temporal analysis of the cocaine metabolite benzoylecgonine in wastewater to estimate community drug use. J Forensic Sci 2012, 57(5):1349-1353.
32. Lai F.Y., Bruno R., Hall W., Gartner C., Ort C., Kirkbride P., et al. Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi-rural and a vacation area. Addiction 2013, 108(3):556-565.
33. Mari F., Politi L., Biggeri A., Accetta G., Trignano C., Di Padua M., et al. Cocaine and heroin in waste water plants: a 1-year study in the city of Florence, Italy. Forensic Sci Int 2009, 189(1-3):88-92.
34. Metcalfe C., Tindale K., Li H., Rodayan A., Yargeau V. Illicit drugs in Canadian municipal wastewater and estimates of community drug use. Environ Pollut 2010, 158(10):3179-3185.
35. Moore K.A., Sklerov J., Levine B., Jacobs A.J. Urine concentrations of ketamine and norketamine following illegal consumption. J Anal Toxicol 2001, 25(7):583-588.
36. NHS Guidelines for dispensing and supervised self administration of methadone by community pharmacists 2009, National Health Service, Lothian.
37. NHS Supervised self administration of methadone and buprenorphine guidelines for pharmacists and pharmacy technicians 2010, National Health Service, Cumbria.
38. NHS Prescription cost analysis England 2010 2011, National Health Sevice, London.
39. ONS Mid-2010 population estimates analysis tool 2010, UK Office for National Statistics, London.
40. Parkin M.C., Turfus S.C., Smith N.W., Halket J.M., Braithwaite R.A., Elliott S.P., et al. Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry. J Chromatogr B 2008, 876(1):137-142.
41. Postigo C., de Alda M.J.L., Barcelo D. Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environ Int 2009, 36(1):75-84.
42. Postigo C., de Alda M.J.L., Barcelo D. Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environ Int 2010, 36(1):75-84.
43. Postigo C., Lopez de Ada M.J., Barcelo D. Analysis of drugs of abuse and their human metabolites in water by LC-MS(2): a non-intrusive tool for drug abuse estimation at the community level. TrAC, Trends Anal Chem 2008, 27(11):1053-1069.
44. Sproule B. Discussion document for the national workshop on preventing the problematic use of psychotropic pharmaceuticals 2006, Centre for Addiction and Mental Health, Toronto.
45. Terzic S., Senta I., Ahel M. Illicit drugs in wastewater of the city of Zagreb (Croatia) - estimation of drug abuse in a transition country. Environ Pollut 2010, 158(8):2686-2693.
46. Thomas K.V., Bijlsma L., Castiglioni S., Covaci A., Emke E., Grabic R., et al. Comparing illicit drug use in 19 European cities through sewage analysis. Sci Total Environ 2012, 432:432-439.
47. U.S.DEA Safety advisory regarding new club drug 'Molly' Retrieved 12/10/2011, from. http://www.justice.gov/dea/pubs/states/newsrel/2003/detroit032103.html.
48. UNODC World drug report 2008 2008, United Nations Office on Drugs and Crime, Vienna.
49. van Nuijs A.L.N., Castiglioni S., Tarcomnicu I., Postigo C., Lopez de Alda M., Neels H., et al. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci Total Environ 2011, 409(19):3564-3577.
50. van Nuijs A.L.N., Mougel J.-F., Tarcomnicu I., Bervoets L., Blust R., Jorens P.G., et al. Sewage epidemiology-a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. Environ Int 2011, 37(3):612-621.
51. van Nuijs A.L.N., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P.G., et al. Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium. Addiction 2009, 104(5):734-741.
52. Wieber J., Gugler R., Hengstmann J.H., Dengler H.J. Pharmacokinetics of ketamine in man. Anaesthesist 1975, 24(6):260-263.
53. Wills S. Drugs of abuse 2005, Pharmaceutical Press, London, UK. 2nd ed.
54. Zessner M., Lindtner S. Estimations of municipal point source pollution in the context of river basin management. Water Sci Technol 2005, 52(9):175-182.
55. Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ Health Perspect 2008, 116(8):1027-1032.
56. Zuccato E., Chiabrando C., Castiglioni S., Calamari D., Bagnati R., Schiarea S., et al. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health 2005, 4:14-21.